Research at the Institute of Biomedicine is divided into three functional units: 1) Infection and Immunity, 2) Integrative Physiology and Pharmacology and 3) Cancer research. Research at our Institute includes both biomedical basic research and translational research, and the unit division expresses our research priorities.
We encourage creative interdisciplinary combination of research topics via collaboration of the individual research groups and the three units. In addition, we collaborate locally with clinical researchers, with other institutes of our university and with the Åbo Akademi University. We are also widely networked with numerous national and international universities and public and private research institutes.
Research services
Recent publications
Ti-MWW Catalysts for Propylene Oxide Production: Influence of Si/Ti Ratio and Calcination Conditions (2023)
Catalysis Letters
(Refereed journal article or data article (A1))
Effect of caldesmon mutations in the development of zebrafish embryos (2023)
Biochemical and Biophysical Research Communications
(Refereed journal article or data article (A1))
Evaluation of plasma IL-21 as a potential biomarker for type 1 diabetes progression (2023)
Frontiers in Immunology
(Refereed journal article or data article (A1))
Melanocortin 1 receptor regulates cholesterol and bile acid metabolism in the liver (2023)
eLife
(Refereed journal article or data article (A1))
Circulating metabolic signatures of rapid and slow progression to type 1 diabetes in islet autoantibody-positive children. (2023)
Frontiers in Endocrinology
(Refereed journal article or data article (A1))
Recent doctoral dissertations
Ti-MWW Catalysts for Propylene Oxide Production: Influence of Si/Ti Ratio and Calcination Conditions (2023)
Catalysis Letters
(Refereed journal article or data article (A1))
Effect of caldesmon mutations in the development of zebrafish embryos (2023)
Biochemical and Biophysical Research Communications
(Refereed journal article or data article (A1))
Evaluation of plasma IL-21 as a potential biomarker for type 1 diabetes progression (2023)
Frontiers in Immunology
(Refereed journal article or data article (A1))
Melanocortin 1 receptor regulates cholesterol and bile acid metabolism in the liver (2023)
eLife
(Refereed journal article or data article (A1))
Circulating metabolic signatures of rapid and slow progression to type 1 diabetes in islet autoantibody-positive children. (2023)
Frontiers in Endocrinology
(Refereed journal article or data article (A1))